Patient-specific dendritic cell vaccines with autologous tumor antigens in 72 patients with metastatic melanoma

AIM: Metastatic melanoma patients were treated with patient-specific vaccines consisting of autologous dendritic cells loaded with antigens from irradiated cells from short-term autologous tumor cell lines. PATIENTS & METHODS: A total of 72 patients were enrolled in a single-arm Phase I/II (NCT0...

Descripción completa

Detalles Bibliográficos
Autores principales: Dillman, Robert O, Cornforth, Andrew N, McClay, Edward F, Depriest, Carol
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2019
Materias:
Clinical Trial Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6688559/
https://www.ncbi.nlm.nih.gov/pubmed/31406564
http://dx.doi.org/10.2217/mmt-2018-0010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6688559/
https://www.ncbi.nlm.nih.gov/pubmed/31406564
http://dx.doi.org/10.2217/mmt-2018-0010

Ejemplares similares